$342.35
-3.93-1.13%
al cierre: -
$342.00
-0.35-0.10%
After hour: Oct 24, 4:25 PM EDT
Elevance Health informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Elevance Health utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ELV | Elevance Health | $3.84 | $3.59 | — | — | $44.99B | $49.66B | — | — | 01/22/2026 | |
ELV | Elevance Health | $8.60 | $4.96 | $6.03 | 21.57% | $44.72B | $49.51B | $50.09B | 1.17% | 10/21/2025 | |
ELV | Elevance Health | $10.12 | $9.19 | $8.84 | -3.81% | $43.22B | $48.21B | $49.42B | 2.50% | 07/17/2025 | |
ELV | Elevance Health | $10.83 | $11.38 | $11.97 | 5.18% | $42.27B | $46.29B | $48.77B | 5.35% | 04/22/2025 | |
ELV | Elevance Health | $5.62 | $3.86 | $3.84 | -0.52% | $42.45B | $44.72B | $44.99B | 0.60% | 01/23/2025 | |
ELV | Elevance Health | $8.99 | $9.66 | $8.37 | -13.35% | $42.48B | $43.33B | $44.72B | 3.21% | 10/17/2024 | |
ELV | Elevance Health | $9.04 | $10.01 | $10.12 | 1.10% | $43.38B | $43.05B | $43.22B | 0.40% | 07/17/2024 | |
ELV | Elevance Health | $9.46 | $10.53 | $10.64 | 1.04% | $41.90B | $42.63B | $42.27B | -0.84% | 04/18/2024 | |
ELV | Elevance Health | $5.23 | $5.64 | $5.62 | -0.35% | $39.67B | $42.09B | $42.45B | 0.86% | 01/24/2024 | |
ELV | Elevance Health | $7.46 | $8.45 | $8.99 | 6.39% | $39.63B | $42.53B | $42.48B | -0.12% | 10/18/2023 | |
ELV | Elevance Health | $7.97 | $8.80 | $9.04 | 2.73% | $38.48B | $41.50B | $43.38B | 4.52% | 07/19/2023 | |
ELV | Elevance Health | $8.19 | $9.26 | $9.46 | 2.16% | $38.09B | $40.83B | $41.90B | 2.62% | 04/19/2023 | |
ELV | Elevance Health | $5.14 | $5.19 | $5.23 | 0.77% | $36.02B | $39.76B | $39.67B | -0.23% | 01/25/2023 | |
ELV | Elevance Health | $6.79 | $7.16 | $7.53 | 5.17% | $35.55B | $39.09B | $39.63B | 1.37% | 10/19/2022 | |
ELV | Elevance Health | $7.03 | $7.74 | $8.04 | 3.88% | $33.28B | $38.13B | $38.48B | 0.92% | 07/20/2022 | |
ELV | Elevance Health | $7.01 | $7.81 | $8.25 | 5.63% | $32.10B | $37.42B | $37.89B | 1.25% | 04/20/2022 | |
ELV | Elevance Health | $2.54 | $5.11 | $5.14 | 0.59% | $31.53B | $36.51B | $36.02B | -1.35% | 01/26/2022 | |
ELV | Elevance Health | $4.20 | $6.39 | $6.79 | 6.26% | $30.65B | $35.30B | $35.55B | 0.70% | 10/20/2021 | |
ELV | Elevance Health | $9.20 | $6.33 | $7.03 | 11.06% | $29.18B | $33.21B | $33.28B | 0.21% | 07/21/2021 | |
ELV | Elevance Health | $6.48 | $6.51 | $7.01 | 7.68% | $29.45B | $32.94B | $32.10B | -2.56% | 04/21/2021 | |
ELV | Elevance Health | $3.88 | $2.52 | $2.54 | 0.79% | $27.13B | $30.78B | $31.53B | 2.45% | 01/27/2021 | |
ELV | Elevance Health | $4.87 | $4.15 | $4.20 | 1.20% | $26.44B | $29.75B | $30.65B | 3.02% | 10/28/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-21 | $6.03 | $4.96 | 21.6 % |
| Q2 | 2025-07-17 | $8.84 | $9.19 | -3.81 % |
| Q1 | 2025-04-22 | $11.97 | $11.38 | 5.18 % |
| Q4 | 2025-01-23 | $3.84 | $3.86 | -0.52 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | 2025-10-21 | $50.09B | $49.51B | 1.17 % |
| Q2 | 2025-07-17 | $49.42B | $48.21B | 2.50 % |
| Q1 | 2025-04-22 | $48.77B | $46.29B | 5.35 % |
| Q4 | 2025-01-23 | $44.99B | $44.72B | 0.60 % |
Está previsto que Elevance Health (ELV) presente resultados el enero 22, 2026. Los últimos resultados se publicaron el octubre 21, 2025 para el Q3.
El BPA real fue de $6.03, que superó la estimación de $4.96.
Los ingresos reales fueron $50.1B, que superó la estimación de $49.5B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.